Effects of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities

Biochemical Pharmacology

Volumn 62, Issue 6, 2001, Pages 765-772

  Rybczynska, Maria ^a   Spitaler, Martin ^a   Knebel, Norbert G ^b   Boeck, Günther ^c   Grunicke, Hans ^a   Hofmann, Johann ^a,d  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b ASTA MEDICA AG   (Germany)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d NONE   (Austria)

Author keywords

Apoptosis; D 21266; Hexadecylphosphocholine; Miltefosine; Sensitivity

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CHOLESTEROL; DOXORUBICIN; MILTEFOSINE; MULTIDRUG RESISTANCE PROTEIN; PERIFOSINE; PHOSPHOLIPID; PHOSPHOLIPID DERIVATIVE; PROTEIN P53; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL CYCLE; CELL CYCLE G2 PHASE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ACCUMULATION; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; DRUG UPTAKE; ENDOCYTOSIS; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID COMPOSITION; LYMPHOMA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL TRANSPORT; CELL CYCLE; CHOLESTEROL; DRUG SCREENING ASSAYS, ANTITUMOR; ENDOCYTOSIS; HUMANS; PHOSPHOLIPIDS; PHOSPHORYLCHOLINE; TUMOR CELLS, CULTURED;

EID: 0035885286     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00715-8     Document Type: Article

References (45)

1. Membrane-interactive lipids as experimental anticancer drugs
2. Analogs of alkyllysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells
3. Alkylphosphocholines: A new class of membrane-active anticancer agents
4. D-21266, a new heterocyclic alkylphospholipid with antitumour activity
5. Uptake, subcellular distribution and metabolism of the phospholipid analogue hexadecylphosphocholine in MDCK cells
6. Biochemistry of multidrug resistance mediated by the multidrug transporter
7. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
8. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene
9. The drug resistance-related protein LRP is the human major vault protein
10. Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine
11. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): Molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L)
12. Alkylphosphocholines induce apoptosis in HL-60 and U-937 leukemic cells
13. Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts
14. Altered expression of the genes regulating apoptosis in multidrug resistant human myeloid leukemia cell lines overexpressing MDR1 or MRP gene
15. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis
16. Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells
17. Isolation and characterization of an anthracycline-resistant human leukemic cell line
18. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
19. A new vector using the human multidrug resistance gene as a selectable marker enables overexpression of foreign genes in eukaryotic cells
20. Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440)
21. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
22. Extraction of tissue lipids with a solvent of low toxicity
23. Assay of inorganic phosphate, total phosphate and phosphatases
24. Theory, analysis and correlation
25. Comparative evolution of endocytosis levels and of the cell surface area during the L929 cell cycle: A fluorescence study with TMA-DPH
26. Quantification of perifosine, an alkylphosphocholine anti-tumour agent in plasma by pneumatically assisted electrospray - Tandem mass spectrometry coupled with high-performance liquid chromatography
27. A rapid single step staining technique for DNA analysis by flow microfluorimetry
28. Rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
29. Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance
30. MDR1 causes resistance to the antitumor drug miltefosine
31. Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis
32. Increased ether lipid cytotoxicity by reducing membrane cholesterol content
33. 2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents
34. Quantification of active caspase 3 in apoptotic cells
35. Investigations on the cellular uptake of hexadecylphosphocholine
36. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues
37. Is the multidrug transporter a flippase?
38. A structure-based mechanism for drug binding by multidrug transporters
39. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity
40. Antagonism of phorbol-ester-stimulated phosphatidylcholine biosynthesis by the phospholipid analogue hexadecylphosphocholine
41. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues
42. 2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine
43. Inhibition of phospholipase C delta by hexadecylphosphorylcholine and lysophospholipids with antitumor activity
44. Multidrug resistance in breast cancer: A meta-analysis of MDR1/Pgp170 expression and its possible functional significance
45. Expression pattern of MRP in human tissues and adult solid tumor cell lines